Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus ointment (Protopic 0.1%) for chronic otitis externa
2006-004441-42Phase 4Terminated
- Sponsor
- Southport and Ormskirk Hospital NHS Trust
- Start
- Dec 2006
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of Envarsus XR in external otitis, sponsored by Southport and Ormskirk Hospital NHS Trust. Primary endpoints: Clinical effectiveness of tacrolimus ointment and Effect on skin and microbiological flora of the external auditory canal. Started Dec 2006; status: terminated.
02
Drugs
Envarsus XR
03
Conditions
external otitis
Beyond the preview
Go deeper on 2006-004441-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004441-42.